Skin pharmacology : the official journal of the Skin Pharmacology Society 1993-01-01

Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.

P Muret, S Makki, S Urien, P Agache, P Bechtel, J P Tillement

Index: Skin Pharmacol. 6(1) , 45-51, (1993)

Full Text: HTML

Abstract

The binding of 5-methoxypsoralen (5-MOP) to human serum and blood fractions was studied by equilibrium dialysis associated to high-performance liquid chromatography. 5-MOP serum binding was 95% and kept constant in the range of therapeutic concentrations. Albumin was the main binding protein with one class of binding sites (n = 2.05) and with a moderate affinity constant (Ka = 10,270 M-1). Free fatty acids (FFA) enhanced 5-MOP binding to albumin. Binding to other proteins, alpha 1-acid glycoprotein, gamma-globulins and lipoproteins (LDL, HDL, VLDL) also occurred, but was negligible. 5-MOP bound to red blood cells (RBCs) with a binding index (ratio of intra- to extra-globular 5-MOP concentrations) of 3.84 and 1.48 in buffer and plasma, respectively. 5-MOP distribution in blood was simulated. The free fraction of 5-MOP in blood could be increased in hypoalbuminemia, unchanged in acute inflammation, and decreased by FFA.


Related Compounds

Related Articles:

[Conductometric method of studying hemocoagulation].

1987-01-01

[Med. Tekh. (3) , 36-40, (1987)]

Differences between exogenous and endogenous noradrenaline in the effects on vascular post-synaptic alpha 1- and alpha 2-adrenoceptors in man.

1985-12-01

[J. Hypertens. Suppl. 3(3) , S145-7, (1985)]

Population studies of Vitamin D Binding Protein microheterogeneity by mass spectrometry lead to characterization of its genotype-dependent O-glycosylation patterns.

2008-09-01

[J. Proteome Res. 7(9) , 4143-53, (2008)]

The Bcl-2 antagonist HA14-1 forms a fluorescent albumin complex that can be mistaken for several oxidized ROS probes.

2008-01-01

[Photochem. Photobiol. 84 , 1272-6, (2009)]

Anti-polymorphonuclear neutrophil antibodies in patients with leukopenia or neutropenia.

2010-02-01

[Int. J. Lab. Hematol. 32(1 Pt 1) , e96-105, (2010)]

More Articles...